Concepedia

Author

Koos de Wit

University of AmsterdamORCID

Also Known As

K De Wit, K de Wit, K. Wit, K. de Wit, Koos de Wit, Victor Vargas

32

Publications

621

Citations

11

H-Index

17

Concepts

All Affiliations

University of AmsterdamAmsterdam UMC Location University of AmsterdamUniversity of AlbertaConsorci Institut D'Investigacions Biomediques August Pi I SunyerUniversity College London
KD

About

Koos de Wit is an author at University of Amsterdam specializing in hepatology, liver physiology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

166

2

Hepatology

3

3

166

3

Pharmacology

3

3

166

4

Health Sciences

1

1

20

5

Metabolism

1

1

20

Koos de Wit

×

9

Publications

404

Citations

9

H-Index

YearCitations

Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial

Elisa Pose, Laura Napoleone, Ahmed Adel Amin,

˜The œLancet. Gastroenterology & hepatology

2019

135

Prevalence, distribution and risk of sessile serrated adenomas/polyps at a center with a high adenoma detection rate and experienced pathologists

Joep IJspeert, Koos de Wit, Manon van der Vlugt,

Endoscopy

2016

90

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)

Koos de Wit, Jelte J. Schaapman, Frederik Nevens,

BMJ Open Gastroenterology

2020

40

Variable efficacy of TIPSS in the management of ectopic variceal bleeding: a multicentre retrospective study

Rosalie C. Oey, Koos de Wit, Adriaan Moelker,

Alimentary Pharmacology & Therapeutics

2018

39

Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium

Elsa Solà, Elisa Pose, Daniela Campion,

Journal of Hepatology

2020

35

Simvastatin and Rifaximin in Decompensated Cirrhosis

Elisa Pose, César Jiménez, Giacomo Zaccherini,

JAMA

2025

23

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis

Elisa Pose, Elsa Solà, Juan José Lozano,

Hepatology Communications

2021

20

Rifaximin stimulates nitrogen detoxification by <scp>PXR</scp>‐independent mechanisms in human small intestinal organoids

Koos de Wit, Ulrich Beuers, Anna Mukha,

Liver International

2022

11

Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial

Elisa Pose, César Jiménez, Giacomo Zaccherini,

Journal of Hepatology

2023

11

Page 1